220 related articles for article (PubMed ID: 17339874)
1. Planning for a national effort to enable and accelerate discoveries in pharmacogenetics: the NIH Pharmacogenetics Research Network.
Long RM
Clin Pharmacol Ther; 2007 Mar; 81(3):450-4. PubMed ID: 17339874
[TBL] [Abstract][Full Text] [Related]
2. How molecular medicine transforms policy (and everything else).
Kean MA; Batchelder KF
J Biolaw Bus; 2004; 7(3):16-9. PubMed ID: 15460603
[TBL] [Abstract][Full Text] [Related]
3. The Affymetrix DMET platform and pharmacogenetics in drug development.
Deeken J
Curr Opin Mol Ther; 2009 Jun; 11(3):260-8. PubMed ID: 19479659
[TBL] [Abstract][Full Text] [Related]
4. National Research Service Awards. Final rule.
National Institutes of Health. Department of Health and Human Services
Fed Regist; 2001 May; 66(105):29498-501. PubMed ID: 11725763
[TBL] [Abstract][Full Text] [Related]
5. Concerning trends and outcomes for National Institutes of Health funding of cancer research.
Bland KI
J Surg Oncol; 2007 Feb; 95(2):161-6. PubMed ID: 17262723
[TBL] [Abstract][Full Text] [Related]
6. NIH public access policy.
Kelley KW
Brain Behav Immun; 2008 Jul; 22(5):629. PubMed ID: 18554561
[No Abstract] [Full Text] [Related]
7. Research ethics. The NIH draft guidelines on human stem cell research.
Majumder MA; Cohen CB
Science; 2009 Jun; 324(5935):1648-9. PubMed ID: 19556488
[No Abstract] [Full Text] [Related]
8. Personalized medicine: building the GPS to take us there.
Ratain MJ
Clin Pharmacol Ther; 2007 Mar; 81(3):321-2. PubMed ID: 17339859
[No Abstract] [Full Text] [Related]
9. Embryonic stem cell research and U.S. policy.
Rao MS
Stem Cells; 2006 Jun; 24(6):1412-3. PubMed ID: 16687466
[No Abstract] [Full Text] [Related]
10. Curb your enthusiasm.
Laurence J
Transl Res; 2007 Jul; 150(1):1-2. PubMed ID: 17585858
[No Abstract] [Full Text] [Related]
11. The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledge.
Hodge AE; Altman RB; Klein TE
Clin Pharmacol Ther; 2007 Jan; 81(1):21-4. PubMed ID: 17185992
[TBL] [Abstract][Full Text] [Related]
12. The NIH, research institutions and industry: working together on a shared goal.
Omary MB
Gastroenterology; 2007 May; 132(5):1647-50. PubMed ID: 17484859
[No Abstract] [Full Text] [Related]
13. A hub for bench-to-bedside pharmacogenomic-based research.
Voora D; Ginsburg GS
Pharmacogenomics; 2011 Aug; 12(8):1095-8. PubMed ID: 21843063
[TBL] [Abstract][Full Text] [Related]
14. Single nucleotide polymorphism wars?
Chauvet JM
Nat Biotechnol; 1998 Feb; 16(2):120. PubMed ID: 9487498
[No Abstract] [Full Text] [Related]
15. The sad and bleak future for urology funding at the National Institutes of Health.
Ellison LM; Olsson CA
Urol Clin North Am; 2009 Feb; 36(1):85-93, vii. PubMed ID: 19038640
[TBL] [Abstract][Full Text] [Related]
16. NIH draft seen as 'working compromise'.
Hutson S
Nat Med; 2009 Jun; 15(6):589. PubMed ID: 19498357
[No Abstract] [Full Text] [Related]
17. Intramural research and training at NINR.
Grady PA
Nurs Outlook; 2007; 55(4):208-9. PubMed ID: 17678687
[TBL] [Abstract][Full Text] [Related]
18. What to expect from the Pharmacogenomics Research Network.
Long RM; Berg JM
Clin Pharmacol Ther; 2011 Mar; 89(3):339-41. PubMed ID: 21326260
[No Abstract] [Full Text] [Related]
19. U.S. science policy. NIH stimulus plan triggers flood of applications--and anxiety.
Kaiser J
Science; 2009 Apr; 324(5925):318-9. PubMed ID: 19372395
[No Abstract] [Full Text] [Related]
20. Troublesome questions.
Civin CI
Stem Cells; 2006 Jun; 24(6):1411. PubMed ID: 16687465
[No Abstract] [Full Text] [Related]
[Next] [New Search]
